CVR number 15243775
Industry 86.2200 Specialist medical practice activities

SPECIALLÆGESELSKABET TESTCENTER TRIANGLEN ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Bankruptcy risk for industry  0.7% 0.7% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 3.9% 12.9% 29.8%  
Credit score (0-100)  0 0 53 20 1  
Credit rating  N/A N/A BBB BB C  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 3,080 -735 -143  
EBITDA  0.0 0.0 2,146 -737 -146  
EBIT  0.0 0.0 2,096 -737 -146  
Pre-tax profit (PTP)  0.0 0.0 2,363.0 -646.0 -169.0  
Net earnings  0.0 0.0 1,843.0 -636.0 -136.7  
Pre-tax profit without non-rec. items  0.0 0.0 2,363 -646 -169  
 
See the entire income statement

Balance sheet (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 1,967 -468 187  
Interest-bearing liabilities  0.0 0.0 0.0 1,501 0.0  
Balance sheet total (assets)  0.0 0.0 2,786 1,159 237  
Net Debt  0.0 0.0 -2,547 365 -191  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 3,080 -735 -143  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 80.6%  
Employees  0 0 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 2,786 1,159 237  
Balance sheet change%  0.0% 0.0% 0.0% -58.4% -79.5%  
Added value  0.0 0.0 2,146.0 -687.0 -146.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 -50 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 -1.0 -2.0  

Profitability 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 68.1% 100.3% 102.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 85.3% -24.5% 5.9%  
ROI %  0.0% 0.0% 120.8% -34.7% -16.2%  
ROE %  0.0% 0.0% 93.7% -40.7% -20.3%  

Solidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Equity ratio %  0.0% 0.0% 70.6% -28.8% 78.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -118.7% -49.5% 131.1%  
Gearing %  0.0% 0.0% 0.0% -320.7% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 6.0% 4.4%  

Liquidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Quick Ratio  0.0 0.0 3.4 0.7 4.7  
Current Ratio  0.0 0.0 3.4 0.7 4.7  
Cash and cash equivalent  0.0 0.0 2,547.0 1,136.0 191.5  

Capital use efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -532.0 -1,534.0 187.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 2,146 -687 -146  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 2,146 -737 -146  
EBIT / employee  0 0 2,096 -737 -146  
Net earnings / employee  0 0 1,843 -636 -137